Switch theme
Sign up to access all valuation multiples
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa and the rest from Americas and Asia Pacific region.
2004
87
LTM Revenue $47.8M
LTM EBITDA $8.3M
$83.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
C-Rad has a last 12-month revenue of $47.8M and a last 12-month EBITDA of $8.3M.
In the most recent fiscal year, C-Rad achieved revenue of $46.6M and an EBITDA of $8.9M.
C-Rad expects next 12-month revenue of XXX and NTM EBITDA of XXX
See C-Rad valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $42.2M | $46.6M | XXX | XXX | XXX |
| Gross Profit | $20.4M | $28.5M | XXX | XXX | XXX |
| Gross Margin | 48% | 61% | XXX | XXX | XXX |
| EBITDA | $5.3M | $8.9M | XXX | XXX | XXX |
| EBITDA Margin | 13% | 19% | XXX | XXX | XXX |
| Net Profit | $0.7M | $3.5M | XXX | XXX | XXX |
| Net Margin | 2% | 8% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, C-Rad's stock price is SEK 29 (or $3).
C-Rad has current market cap of SEK 986M (or $97.9M), and EV of SEK 844M (or $83.8M).
See C-Rad trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $83.8M | $97.9M | XXX | XXX | XXX | XXX | $0.18 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, C-Rad has market cap of $97.9M and EV of $83.8M.
C-Rad's trades at 1.8x LTM EV/Revenue multiple, and 10.1x LTM EBITDA.
Analysts estimate C-Rad's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for C-Rad and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $83.8M | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 9.4x | XXX | XXX | XXX |
| P/E | 17.5x | XXX | XXX | XXX |
| P/E/Growth | 0.6x | XXX | XXX | XXX |
| EV/FCF | 36.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpC-Rad's NTM/LTM revenue growth is 11%
C-Rad's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, C-Rad's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate C-Rad's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for C-Rad and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 69% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 30% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 54% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
C-Rad acquired XXX companies to date.
Last acquisition by C-Rad was XXXXXXXX, XXXXX XXXXX XXXXXX . C-Rad acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was C-Rad founded? | C-Rad was founded in 2004. |
| Where is C-Rad headquartered? | C-Rad is headquartered in Sweden. |
| How many employees does C-Rad have? | As of today, C-Rad has 87 employees. |
| Who is the CEO of C-Rad? | C-Rad's CEO is Ms. Cecilia de Leeuw. |
| Is C-Rad publicy listed? | Yes, C-Rad is a public company listed on STO. |
| What is the stock symbol of C-Rad? | C-Rad trades under CRAD B ticker. |
| When did C-Rad go public? | C-Rad went public in 2007. |
| Who are competitors of C-Rad? | Similar companies to C-Rad include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of C-Rad? | C-Rad's current market cap is $97.9M |
| What is the current revenue of C-Rad? | C-Rad's last 12-month revenue is $47.8M. |
| What is the current EBITDA of C-Rad? | C-Rad's last 12-month EBITDA is $8.3M. |
| What is the current EV/Revenue multiple of C-Rad? | Current revenue multiple of C-Rad is 1.8x. |
| What is the current EV/EBITDA multiple of C-Rad? | Current EBITDA multiple of C-Rad is 10.1x. |
| What is the current revenue growth of C-Rad? | C-Rad revenue growth between 2023 and 2024 was 10%. |
| Is C-Rad profitable? | Yes, C-Rad is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
